Medico Intercontinental holds 42nd AGM, adopts FY26 financials
- 42nd AGM held on September 30, 2026, via video conferencing
- Audited FY26 standalone and consolidated financial statements adopted
- Approval sought for related party transactions with five entities
- Samir Shah elected as Chairman; Yash Mehta appointed as scrutinizer

*this image is generated using AI for illustrative purposes only.
Medico Intercontinental Limited held its 42nd Annual General Meeting on September 30, 2026, through video conferencing. The meeting focused on adopting the audited financial statements for the fiscal year ended March 31, 2026, and approving several related party transactions.
Samir Shah was unanimously elected as the Chairman of the meeting. He briefed members on the company's business performance and expressed gratitude to stakeholders. The requisite quorum was present, allowing the meeting to proceed in compliance with the Companies Act, 2013, and MCA circulars permitting virtual meetings.
Key agenda items transacted
The notice convening the meeting, dated August 14, 2026, outlined both ordinary and special business. Members considered the following resolutions:
| Agenda Item | Type | Details |
|---|---|---|
| Adoption of Financial Statements | Ordinary | Standalone and Consolidated for FY26 |
| Director Reappointment | Ordinary | Swati Jay Shah (DIN: 08420884) |
| Related Party Transactions | Special | Oxford Pharma, LYF Distributor, Medico Lab |
| Related Party Transactions | Special | Calborn Lifescience Private Limited |
| Related Party Transactions | Special | Samir D Shah |
Swati Jay Shah retired by rotation and offered herself for reappointment, which was approved by the members. The special business involved seeking approval for entering into related party transactions with five entities, including Oxford Pharma, LYF Distributor, Medico Lab, Calborn Lifescience Private Limited, and Samir D Shah.
Voting and scrutiny process
All voting was conducted electronically via the CDSL platform to ensure transparency. The e-voting period opened at 9:00 am on September 27, 2026, and concluded at 5:00 pm on September 29, 2026. Members who had not voted earlier were permitted to cast their votes during the AGM.
Yash Mehta, a practicing company secretary, was appointed as the scrutinizer to oversee the remote e-voting process and the voting conducted during the meeting. The scrutinizer’s report is expected to be submitted within two working days of the conclusion of the AGM. Subsequently, the voting results will be declared and uploaded to the company website and forwarded to the stock exchanges in accordance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Compliance and conclusion
The meeting complied with Rule 20 of the Companies (Management and Administration) Rules, 2014, regarding electronic voting options. Queries raised by shareholder speakers during the proceedings were addressed by the Company Secretary and the Managing Director. The meeting concluded at 2:17 pm with a vote of thanks to the chair and participating members.
Historical Stock Returns for Medico Intercontinental
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.13% | +1.88% | -9.14% | -4.79% | -30.96% | -38.99% |
How will the approved related party transactions with Oxford Pharma and Medico Lab impact Medico Intercontinental's operational dependencies and cost structures in FY27?
What specific revenue growth or margin improvements were reported in the FY26 audited financial statements to justify the current valuation?
Will the reappointment of Swati Jay Shah signal any strategic shifts in the company's corporate governance or expansion plans?


































